Challenging Therapeutics IP After Fed. Circ. Drink Can Ruling
The U.S. Court of Appeals for the Federal Circuit's Dec. 31 opinion in Ball Metal Beverage Container Corp. v. Crown Packaging Technology Inc.,[1] though nonprecedential, raises important considerations for pharmaceutical and...To view the full article, register now.
Already a subscriber? Click here to view full article